Abstract
Diabetes Mellitus and obesity, now coined as “Diabesity”, is a worldwide
epidemic that imposes a huge burden on healthcare and society. Diabesity has been
associated with poor outcomes and increased morbidity and mortality. The kidneys are
a vulnerable target of diabesity. In this chapter, we discuss the epidemiology,
pathophysiology, and treatment of diabesity–induced kidney disease. We specifically
focus on the therapeutic targets and pharmacological management of diabesity-related
kidney diseases.
Related Journals
Current Dentistry
Current Traditional Medicine
Adolescent Psychiatry
New Emirates Medical Journal
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Endocrine, Metabolic & Immune Disorders - Drug Targets
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Current Diabetes Reviews
Related Books
Andrology: Current and Future Developments
Male Infertility: An Integrative Manual of Western and Chinese Medicine
Recent Advances in Anesthesiology
Recent Advances in Anesthesiology
Recent Advances in Anesthesiology
Recent Advances in Anesthesiology
Awake Thoracic Surgery
The Anatomical Foundations of Regional Anesthesia and Acute Pain Medicine Macroanatomy Microanatomy Sonoanatomy Functional anatomy
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents